Nasdaq listing
Published: March 22, 2017
Top stories
Digital health – February 16, 2026
It is the first AI operating system in Europe to achieve registration in EUDAMED as a medical device, according to the company.
MedTech Business – February 16, 2026
Amferia’s antibacterial wound dressing has been granted approval by the US Food and Drug Administration (FDA) through the De Novo Classification Request track, allowing Amferia to enter the US market with a unique Class 2 medical device antibacterial dressing for advanced wound care.
Agreement – February 16, 2026
Suzhou Ribo Life Science and its Swedish subsidiary Ribocure Pharmaceuticals have entered into an exclusive worldwide licensing agreement with Madrigal Pharmaceuticals for six pre-clinical small interfering RNA (siRNA) programs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
Career choice – February 16, 2026
María Bueno Álvez is a final year PhD student at SciLifeLab and the KTH Royal Institute of Technology, working in the Human Protein Atlas under the supervision of Professor Mathias Uhlén.
Related posts
This site uses cookies